9 Nov 2018 13:48
EKF Diagnostics Holdings plc
("EKF", the "Company")
Director/PDMR Shareholding
EKF Diagnostics Holdings plc (AIM: EKF) announces that on 9 November 2018, the Company was notified by Adam Reynolds, Non-executive Director, that he has today sold 1,250,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares").
Following the above transaction, which was completed on 9 November 2018 at a price of 27.25 pence per share, Adam Reynolds is now interested in 2,068,613 Ordinary Shares, representing 0.45% of the Company's issued share capital.
EKF Diagnostics Holdings plc | www.ekfdiagnostics.com |
Christopher Mills, Non-Executive Chairman | Tel: 029 2071 0570 |
Julian Baines, CEO | |
Richard Evans, FD & COO | |
N+1 Singer (Nomad & Broker) | Tel: 020 7496 3000 |
Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance) Tom Salveson (Corporate Broking) | |
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com | |
Paul McManus/ Lianne Cawthorne | Mob: 07980 541 893 / 07584 391 303 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Adam Reynolds | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Non-executive Director
| ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| EKF Diagnostics Holdings plc | ||||
b)
| LEI
| 213800DXTF3EAUK1AR05 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 1p each ("Ordinary Shares")
ISIN Code: GB0031509804
| ||||
b)
| Nature of the transaction
| Sale of shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
| n/a | ||||
e)
| Date of the transaction
| 9 November 2018 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
Ekf Diagnostics (EKF)